ioSensory neurons imaged by immunocytochemistry

cat no | ioEA1024 Early Access

ioSensory Neurons

Highly pure human iPSC-derived sensory neurons with a defined nociceptor identity

ioSensory Neurons are a highly pure, easy to use and functional in vitro nociceptor model, enabling reliable chronic nociceptive pain research and therapeutics development for peripheral neuropathies.

ioSensory Neurons are precision reprogrammed using opti-ox™ technology, meaning consistency is built-in. Within 7 days post-revival, ioSensory Neurons form a highly pure (>99%) sensory neuronal population with a defined nociceptor identity, characterised by the expression of the pan-sensory neuron markers, PRPH, BRN3A, ISL1 and TUBB3, and key markers of nociceptors, NTRK1 and TRPV1.

These cells display spontaneous activity and show a functional nociceptor phenotype, as demonstrated by responsiveness to selective agonists for TRPV1, TRPM3, and TRPM8. 

Register your interest for Early Access vials now

A member of our team will be in touch to arrange a follow-up conversation. 

Unsure where to start?

Get in touch and we'll guide the way!

Benchtop benefits

pure_0

Highly Pure

>99% pure sensory neurons with a defined nociceptor identity by day 7 post-revival, as confirmed by single cell RNA sequencing.

functional_0

Functional

ioSensory Neurons display spontaneous activity and a functional nociceptor phenotype, as shown by calcium mobilisation in response to specific TRP agonists.

easy_0

Easy to use

Cryopreserved cells arrive, programmed to mature rapidly upon revival. Simple two-step protocol using one medium – no mitomycin C treatment is necessary.

Product information

Starting material

Human iPSC line

Karyotype

Normal (46, XY)

Seeding compatibility

6, 12, 24, 96 and 384 well plates

Shipping info

Dry ice

Donor

Caucasian adult male (skin fibroblast)

Vial size

Small: >2 x 10⁶ viable cells

Quality control

Sterility, protein expression (ICC) and gene expression (RT-qPCR)

Differentiation method

opti-ox cellular reprogramming

Recommended seeding density

60,000 cells/cm²

User storage

LN2 or -150°C

Format

Cryopreserved cells

Product use

ioCells are for research use only

Applications

Chronic pain research & drug development
MEA analysis
Calcium imaging
Transcriptome analysis
Neurotoxicology

Technical data

Ready within days

opti-ox precision reprogrammed ioSensory Neurons rapidly form a homogenous neuronal population

Time-lapse video capturing the rapid and homogeneous neuronal phenotype acquisition upon thawing of cryopreserved ioSensory Neurons. 14 day time course.

Highly characterised and defined

ioSensory Neurons express pan-sensory neuron-specific markers 

bitbio-ioSensory_Neurons-ICC_Comparison V2

Immunofluorescent staining of ioSensory Neurons at day 14 post-revival. The upper panel shows that ioSensory Neurons are positive for BRN3A (red), the pan-neuronal marker MAP2 (green), and the DAPI counterstain (blue), and demonstrates that all MAP2 positive neurons have a sensory neuronal identity. The lower panel shows that ioSensory Neurons are positive for ISL1 (magenta), PRPH (red), the pan-neuronal marker TUBB3 (green), and the DAPI counterstain (blue).

ioSensory Neurons show visible neuronal networks by day 7

bitbio-ioSensory_Neurons-Morphology_Timeline-correction

Upon reprogramming, rapid morphological changes are observed in the cells, with neurons identified by day 4 post-revival. Visible neuronal networks are observed by day 7 post-thaw. Images show day 1 to 14 post-thawing; 10X magnification; scale bar: 200 μm.

Single cell RNA-sequencing shows ioSensory Neurons form a pure population (>99%) of sensory neurons

bitbio-ioSensory_Neurons-scRNA-mature-correct-key-small-V2

Single cell RNA-sequencing analysis was performed with ioSensory Neurons at four specific timepoints (days 7, 10, 14 and 17). By day 7, the population has a distinct expression profile indicating a pure population (>99%) of post-mitotic sensory neurons. Gene expression was assessed by 10x Genomics scRNA-sequencing. Note, this data is from cells in continuous culture and not cryopreserved cells.

Single cell RNA-sequencing shows ioSensory Neurons express key pan-sensory neuronal markers

bitbio-ioSensory_Neurons-scRNA-nociceptor-pansensory-correction

Single cell RNA-sequencing analysis was performed with ioSensory Neurons at four specific timepoints (days 7, 10, 14 and 17). By day 7, the expression of pan-sensory neuron marker genes, ISL1, ISL2, PRPH, BRN3A, together with the pan-neuronal markers TUBB3 and MAP2, could be detected in post-mitotic sensory neurons. Gene expression was assessed by 10x Genomics scRNA-sequencing. Note, this data is from cells in continuous culture and not cryopreserved cells.

Single cell RNA-sequencing shows ioSensory Neurons express key nociceptor markers

bitbio-ioSensory_Neurons-scRNA-key-nociceptor

Single cell RNA-sequencing analysis was performed with ioSensory Neurons at four specific timepoints (days 7, 10, 14 and 17). By day 7, the expression of key nociceptor marker genes (NTRK1 and TRPV1) could be detected in post-mitotic sensory neurons. Gene expression was assessed by 10x Genomics scRNA-sequencing. Note, this data is from cells in continuous culture and not cryopreserved cells.

Rapid gain of functional activity

ioSensory Neurons display spontaneous activity that matures over time
bitbio-ioSensory_Neurons-MEA_Data

Multi electrode array (MEA) recordings of ioSensory Neurons at days 6 and 17. The activity maps show firing rate (A), spike amplitude (B) and % of active electrodes (C). Results demonstrate a time-dependent increase of spontaneous activity during neuronal maturation from day 6 to day 17. Analysis was performed on a Maxwell Biosystem's MaxTwo multi-well system. Note, this data is from cells in continuous culture and not cryopreserved cells.

ioSensory Neurons display a functional nociceptor phenotype
bitbio-ioSensory_Neurons-Calcium_Mobilization
Calcium mobilisation imaging upon stimulation of ioSensory Neurons with pharmacological agonists targeting thermosensitive TRP channels such as TRPV1 (capsaicin), TRPM3 (CIM0216) and TRPM8 (WS-12). Active traces represent the increase in intracellular calcium mobilisation of individual cells upon exposure to noxious stimuli but not to vehicle at day 17. This indicates that cells display a functional nociceptor phenotype within 17 days. Note, this data is from cells in continuous culture and not cryopreserved cells.
Calcium imaging of ioSensory Neurons demonstrates activity following treatment with a TRPM3 agonist
Representative video of ioSensory Neurons displaying calcium mobilisation in response to treatment with the TRPM3 agonist, CIM0216. Note, this data is from cells in continuous culture and not cryopreserved cells.

Cells arrive ready to plate

bitbio-iosensory_neurons-diagram

ioSensory Neurons are delivered in a cryopreserved format and are programmed to rapidly mature upon revival in the recommended media. The protocol for the generation of these cells is a three-phase process: Induction, which is carried out at bit.bio (Phase 0), Stabilisation for 7 days (Phase 1), and Maintenance (Phase 2) during which the ioSensory Neurons mature. Phases 1 and 2 after revival of cells are carried out by the customer.

Product resources

Rethinking Developmental Biology With Cellular Reprogramming Webinar
Rethinking Developmental Biology With Cellular Reprogramming

Mark Kotter | CEO and founder | bit.bio


Marius Wernig | Professor Departments of Pathology and Chemical and Systems Biology |  Stanford University


2023

Watch now
Modelling human neurodegenerative diseases in research & drug discovery Webinar
Modelling human neurodegenerative diseases in research & drug discovery

Charles River Laboratories &  bit.bio

Watch now
Stem Cells and Functional Genomic Screening | Talk Talk
Stem Cells and Functional Genomic Screening | Talk

Kam Dhaliwal | SVP Strategic Alliances | bit.bio


Talk at ELRIG CRISPR in Drug Discovery

Watch now
Accelerating in vitro target and drug discovery using reprogrammed glutamatergic neurons Video
Accelerating in vitro target and drug discovery using reprogrammed glutamatergic neurons

Dr Shushant Jain | Group Leader In Vitro Biology | Charles River

Interview at SLAS

Watch now

Differentiating iPSCs - which approach works best? 

Download this infographic to find out how the approach used to generate human iPSC-derived cells influences purity, batch consistency and protocol speed. 

bit.bio-opti-ox-infographic in hand-Aug 2022

Related products

ioMicroglia™ ioWild Type
ioMicroglia™ cat no. ioA021
Order now
ioGABAergic Neurons™ ioWild Type
ioGABAergic Neurons™ cat no. ioEA1003S
Order now
ioSkeletal Myocytes™ ioWild Type
ioSkeletal Myocytes™ cat no. io1002
Order now
ioGlutamatergic Neurons™ ioWild Type
ioGlutamatergic Neurons™ cat no. io1001
Order now

Related pages

Discover ioCells Learn about our range of human iPSC-derived cells for research and drug discovery
Resources Explore our latest scientific insights, webinars, blogs and videos
Our platform Discover the cell identity coding platform that powers our ioCells